Garen G Bohlin's Net Worth
$2.65 Million
Who is Garen G Bohlin?
Garen G Bohlin has an estimated net worth of $2.65 Million. This is based on reported shares across multiple companies, which include ACUSPHERE INC, TETRAPHASE PHARMACEUTICALS INC, Targanta Therapeutics Corp., Sirtris Pharmaceuticals, Inc., COLLEGIUM PHARMACEUTICAL, INC, Karyopharm Therapeutics Inc., PROTEON THERAPEUTICS INC, and PRAECIS PHARMACEUTICALS INC.
SEC CIK
Garen G Bohlin's CIK is 0001254705
Past Insider Trading and Trends
2017 was Garen G Bohlin's most active year for acquiring shares with 7 total transactions. Garen G Bohlin's most active month to acquire stocks was the month of April. 2024 was Garen G Bohlin's most active year for disposing of shares, totalling 2 transactions. Garen G Bohlin's most active month to dispose stocks was the month of April. 2024 saw Garen G Bohlin paying a total of $166,084.05 for 105,678 shares, this is the most they've acquired in one year. In 2024 Garen G Bohlin cashed out on 57,970 shares for a total of $936,311.15, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACUSPHERE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +163.66% | 94.94K |
$0.08 | $7,500.02 | 152.94K |
Jan 2
| |||
Form 4
| +43.00% | 17.44K |
$0.43 | $7,500.06 | 58.01K |
Oct 1
| |||
Form 4
| +35.22% | 10.56K |
$0.71 | $7,500.09 | 40.56K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
| No matching records found | |||||||||
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Targanta Therapeutics Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sirtris Pharmaceuticals, Inc. No price found
COO and Assistant Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 55K |
—
|
—
| 55K |
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $37.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.18% | 7.69K |
$19.02 | -$770,227.10 | 52.47K |
May 14 - May 16
| |||
Form 4
| +27.99% | 9.79K |
—
|
—
| 44.77K |
May 18
| |||
Form 4
| +67.00% | 14.04K |
—
|
—
| 34.98K |
May 19
| |||
Form 4
| +90.32% | 9.94K |
—
|
—
| 20.95K |
May 20
| |||
Form 4
| +58.15% | 4.05K |
—
|
—
| 11.01K |
May 20
| |||
Form 4
| +208.92% | 4.71K |
—
|
—
| 6.96K |
Apr 25
| |||
Form 4
|
∞
| 2.25K |
—
|
—
| 2.25K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||